| Term 
 
        | what are the 4 main uses for estrogen or progesterone drugs |  | Definition 
 
        | hormone replacement therapy / post-menopause 
 contraception
 
 health benifits of contraception
 
 receptor antagonist: breast cancer, infertility
 |  | 
        |  | 
        
        | Term 
 
        | what is another name for the follicular phase, how long is it |  | Definition 
 
        | proliferative phase, length varies |  | 
        |  | 
        
        | Term 
 
        | what are the two phases of the menstural cycle |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what is another name for the lutela phase, how long is it |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | explain the process of hormone production in the follicular phase |  | Definition 
 
        | pulses of GnRH cause release of LH and FSH estrogen increases reduce LH and FSH release
 inhibin is mad ein ovary and causes feedback decreasing FSH
 mid cycle estrogen reaches peak for 36 hours and stops inhibiting gonadotropins and causes surge instead
 |  | 
        |  | 
        
        | Term 
 
        | what happens in the luteal phase |  | Definition 
 
        | corpus luteum secretes progesterone (estrgen levels stay elevated) if pregnancy does not occur corpus luteum regresses due to lack of LH and progesterone and falls so endometrium sheds causing menstural discharge
 |  | 
        |  | 
        
        | Term 
 
        | what does progesterone do for the baby/uterus |  | Definition 
 
        | stops endometrium proliferation helps with implantation and growth of blastocyst
 causes growth of endometrial vessels
 |  | 
        |  | 
        
        | Term 
 
        | what is the general structure of estrogen |  | Definition 
 
        | 18C with an aromatic phenolic acid ring (required for selective high affinity binding) |  | 
        |  | 
        
        | Term 
 
        | what is the natural form of estrogen, where is it made in men and women |  | Definition 
 
        | 17B estradiol 
 women: ovarian granulosa cells
 men and post-menopause; adipose tissue viea DHEA from adrenal cortex
 |  | 
        |  | 
        
        | Term 
 
        | what stimulates for estrogen release |  | Definition 
 
        | gonadotropins stimulate aromatase |  | 
        |  | 
        
        | Term 
 
        | what are precursors for estrogen |  | Definition 
 
        | androstendione testosterone
 |  | 
        |  | 
        
        | Term 
 
        | estrogen needs aromatic ring to work, how does it get it |  | Definition 
 
        | aromatase using NADPH and O |  | 
        |  | 
        
        | Term 
 
        | where are estrogen receptors located |  | Definition 
 
        | ovarian granulosa, sertoli and leydig cells, stroma of adipose, placenta, blastocyte, brain |  | 
        |  | 
        
        | Term 
 
        | how is estrogen converted between its different forms |  | Definition 
 
        | estradiol oxidized to esterone via 12-hydroxysteroid DH 
 estradiol and esterone converted to estriol
 |  | 
        |  | 
        
        | Term 
 
        | what is the down side of using natural progesterone |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what are the two types of synthetic progesterone |  | Definition 
 
        | 21C progesterone skeletons 19-nortestosterone
 |  | 
        |  | 
        
        | Term 
 
        | what is 19-nortestosterone |  | Definition 
 
        | progesterone without C19, 20, 21 resembles testosterone more so has effects of both
 |  | 
        |  | 
        
        | Term 
 
        | where is progesterone made, when |  | Definition 
 
        | made in testis, adrenal cortex, placenta, and ovary corpus luteum 
 begins being made in follicular phase and increases in luteal phase later in pregnancy
 |  | 
        |  | 
        
        | Term 
 
        | what is the relationship between progesterone and the cns |  | Definition 
 
        | increases body temp 1 deg midcycle until onset of menstural flow (ovulation) |  | 
        |  | 
        
        | Term 
 
        | what is the down side to using estrogen alone in hormone replacement |  | Definition 
 
        | risk of endometrial carcinoma due to hyperplasia of the endometrium |  | 
        |  | 
        
        | Term 
 
        | what is the benifit of combined estrogen progesterone therapy in hormone replacement |  | Definition 
 
        | estrogen receptors dont get out of hand because it has to make some progesterone receptors too |  | 
        |  | 
        
        | Term 
 
        | how is a post-menopausal women with a uterus treated forr hormone replacement |  | Definition 
 
        | progesterone/estrogen combination |  | 
        |  | 
        
        | Term 
 
        | what are contraindications to progesterone/estrogen hormon replacement |  | Definition 
 
        | unable to tolerate progestins risk of cardiovascular disease
 poorlipoproteins use estrogen alone
 |  | 
        |  | 
        
        | Term 
 
        | how is a post-menopausal women with a hysterctomy treated for homeone replacement |  | Definition 
 
        | estrogen alone, no where for it to cause carcinoma |  | 
        |  | 
        
        | Term 
 
        | what are 4 ways to administer hormone replacement therapy |  | Definition 
 
        | cyclic continous
 transdermal patch
 vaginal ring
 |  | 
        |  | 
        
        | Term 
 
        | what is the redigmen for cyclic hormone replacement |  | Definition 
 
        | estrogen 15d estrogen and progesterone 10d
 repeat
 |  | 
        |  | 
        
        | Term 
 
        | what is the redigmen for continous hormone replacement |  | Definition 
 
        | estrogen and progesterone daily OR
 estrogen and progesterone 10d
 esteogrn 15d
 repeat
 |  | 
        |  | 
        
        | Term 
 
        | what are the contents of combination oral contraceptives |  | Definition 
 
        | estrogen: ethinyl estradiol or mestraol progesterone: norethindrone or norgestrel
 |  | 
        |  | 
        
        | Term 
 
        | what are the three types of oral contraceptives |  | Definition 
 
        | monophasic biphasic
 triphasic
 |  | 
        |  | 
        
        | Term 
 
        | how are monophasic oral contraceptives administered |  | Definition 
 
        | same amount of estrogen and progesterone in each tablet for 21d |  | 
        |  | 
        
        | Term 
 
        | how are biphasic oral contraceptives administred |  | Definition 
 
        | two tablets with different amounts for 21 days |  | 
        |  | 
        
        | Term 
 
        | what is the benifit of biphasic oral contraceptives |  | Definition 
 
        | reduce steroids administred because it approximates estrogen to progesterin ratio of menstural cycle |  | 
        |  | 
        
        | Term 
 
        | how are triphasic oral contraceptives administered |  | Definition 
 
        | three tablets with different amounts for 21 days |  | 
        |  | 
        
        | Term 
 
        | what is the general MOA of contraceptives |  | Definition 
 
        | estrogen supresses FSH and stops follicular development proteitiating action of progestrin which stops LH surfe
 progesterin stops ovulation, thickens cervical mucous, and causes endometrial atrophy
 estrogen stabilizes endometrial lining (bleeding control)
 |  | 
        |  | 
        
        | Term 
 
        | what are 4 contraindications to oral contraceptives |  | Definition 
 
        | thrombotic disease over 35 and smoking
 hormone sensitive tumor (breast canceR)
 pregnancy
 |  | 
        |  | 
        
        | Term 
 
        | what are the 4 forms of estrogen, talk about the bioavailability and blood distribution of each |  | Definition 
 
        | natural: 12B estradiol, esterone, estriol: poor oral bioavailability high first pass effect 
 17B estradiol estrace: microcrystaline form, reduced first pass
 |  | 
        |  | 
        
        | Term 
 
        | what are the benifits of a transdermal estrogen patch |  | Definition 
 
        | slow release increased bioavailability
 constant blood levels
 |  | 
        |  | 
        
        | Term 
 
        | what are the 4 types of synthetic estrogens |  | Definition 
 
        | conjugated ethinyl estradiol
 menastrol
 estradiol cruptionate
 |  | 
        |  | 
        
        | Term 
 
        | what is conjugated estrogen made of where does it come from |  | Definition 
 
        | many conjugated estrogen metabolites pregnant mares
 |  | 
        |  | 
        
        | Term 
 
        | what is the structure of ethinyl estradiol |  | Definition 
 
        | ethinyl group on C17 of estrace nucleus |  | 
        |  | 
        
        | Term 
 
        | how is mestranol metabolized |  | Definition 
 
        | prodrug converted to ethinyl estradiol
 |  | 
        |  | 
        
        | Term 
 
        | what is a non-steroidal estrogen agonist |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what is the MOA of oestrogen contraceptives |  | Definition 
 
        | passivly diffuse into cell 
 bind nuclear receptors in genital, breast, HPA, bone, and liver
 
 interact with estrogen response elements (ERE) which alter transcription
 
 supress FSH stopping follicle development and stabilizing endometrial lining (bleeding control)
 |  | 
        |  | 
        
        | Term 
 
        | what are the 12 negative side effects of estrogen contraceptives |  | Definition 
 
        | elevated TG decrease bile acid (due to cholesterol secretion)
 removal: hot flashes, chills, sweating, parasthesia
 
 nausea
 cramping
 fluid retention
 dizzy
 headache
 breast tenderness
 Mi or thrombosis in women >35 who smoke
 |  | 
        |  | 
        
        | Term 
 
        | what are the good side effects of estrogen contraceptives (and natural functions) (14) |  | Definition 
 
        | decrease cholesterol increase HDL
 decrease LDL
 
 growth of uterus, vagina, fallopian tubes, breast, ducts, sexual development
 
 fat distribution, growth spurt, fusion of epiphysis
 
 increase plasma binding proteins
 
 prevent bone loss: block reabsorption
 
 decrease endometrial and ovarian cancer
 
 decrease fibroadenomas, fibrocysts, PID
 
 decrease blood loss and cause cycle regularity
 |  | 
        |  | 
        
        | Term 
 
        | why are esgtrogen contraceptives used (7) |  | Definition 
 
        | contraception replacement
 fibroadenomas
 fibrocysts
 PID
 cycle regularity
 failure of ovarian development
 |  | 
        |  | 
        
        | Term 
 
        | what are three diseases that include failure of ovarian development |  | Definition 
 
        | dwarfism turner syndrome
 hypopituitarism
 |  | 
        |  | 
        
        | Term 
 
        | what is the administration of the 4 estrogen contraceptives |  | Definition 
 
        | conjugated: oral active ethinyl estradiol: oral active
 mestranol: not for replacement
 estradiol crypionate: long acting given IM
 |  | 
        |  | 
        
        | Term 
 
        | how are estrogen drugs excreted |  | Definition 
 
        | in urine with glucourindes and sulfate conjugates |  | 
        |  | 
        
        | Term 
 
        | what are the side effects of diethylstilbesterol |  | Definition 
 
        | congenital abnormalities in fetus |  | 
        |  | 
        
        | Term 
 
        | why would you use diethylstilbesterol |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what are the three antiestrogen drugs |  | Definition 
 
        | chlomiphene tamoxifen
 raloxifene
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | competitive agonist of estrogen binding 
 stimulates ovulation in women with normal HPA and estrogen levels by opposing negative feedback increasing gonadotropin pulse amplitude (not frequency)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | competitive antagonist of estrogen binding antagonizes receptor
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | partial agonist effect on bone reabsorption and plasma lipoproteins NO effect on reproductive tissues
 selective estrogen receptor modulator
 |  | 
        |  | 
        
        | Term 
 
        | what is the structure of clomiphene |  | Definition 
 
        | mixed isomeres cis has estrogenic activity
 trans has anti-estrogenic activity
 |  | 
        |  | 
        
        | Term 
 
        | what is the structure of tamoxifen |  | Definition 
 
        | pure trans isomere (only the useful part of clomiphene) |  | 
        |  | 
        
        | Term 
 
        | why would you use clomiphene |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | why would you use tamoxifen |  | Definition 
 
        | block hormone induced breast tumors 
 adjunct with surgery or chemo
 |  | 
        |  | 
        
        | Term 
 
        | why would you use raloxifene |  | Definition 
 
        | osteoperosis post-menopause |  | 
        |  | 
        
        | Term 
 
        | what are the side effects of clomiphene (6 |  | Definition 
 
        | ovarian hyperstimulation increased multiple births
 ovarian cysts
 anti-estrogenic: follicle, endometrium, cervical mucous (counter active)
 |  | 
        |  | 
        
        | Term 
 
        | what are the side effects of tamoxifen (3) |  | Definition 
 
        | decrease tumor development in other breast endometrial carcinoma
 hormone independent breast tumors
 |  | 
        |  | 
        
        | Term 
 
        | how is clomiphene administered, half life, where metabolized, where excreted |  | Definition 
 
        | oral t.5 = 5-7d
 hepatic metabolism
 GI excretion
 |  | 
        |  | 
        
        | Term 
 
        | tamoxifen: aministration, metabolism, excretion |  | Definition 
 
        | oral hepatic metabolism
 Gi excretion
 |  | 
        |  | 
        
        | Term 
 
        | explain how tamoxifen is eliminated |  | Definition 
 
        | phase 1: 4-11d phase 2: 4d (hydroxytamoxifen)
 |  | 
        |  | 
        
        | Term 
 
        | what are the two aromatase modifying drugs |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | selective aromatase inhibitor stops conversion of androgens to estrogens reversible
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | aromatase inactivastor acts as false substrate for enzyme and intermediate irreversibly binding to acrive site (suicide inhibition) stopping conversion of androgens to estrogens 
 irreversible
 |  | 
        |  | 
        
        | Term 
 
        | what is the clinical use of amastrazole |  | Definition 
 
        | post-menopausal hormone dependent breast cancer |  | 
        |  | 
        
        | Term 
 
        | what is the use of exemestane |  | Definition 
 
        | post-menopausal hormone dependent breast cancer |  | 
        |  | 
        
        | Term 
 
        | what is an anti-progesterin drug, what progesterin structure family is it from |  | Definition 
 
        | mifepristone 
 19-nortestosterone derivative
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | potent competitive inhibitor of progesterone and glucocorticoids 
 decrease in progesterone cause abortion by detaching blastocyst
 
 myometrial contraction and cervical softening allow for expulsion
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | administer up until 49 days after pregnancy abortion pill
 |  | 
        |  | 
        
        | Term 
 
        | what are the 4 progesterone contraceptives and their progesterone structure family |  | Definition 
 
        | norethindrone: 19-nortestosterone norgestrel: 19-nortestosterone
 mexroxyprogesterone acetate: 21C progesterone
 progestasert
 |  | 
        |  | 
        
        | Term 
 
        | what is the admnistration of the 4 progesterone contraceptives |  | Definition 
 
        | norethindrone: oral norgestrel: oral, subdermal (5y)
 mexroxyprogesterone acetate: IM (3mo)
 progestasert: intrauterine
 |  | 
        |  | 
        
        | Term 
 
        | MOA progesterone contraceptives |  | Definition 
 
        | supresses LH surge thickens cervical mucous
 decreases endometrial proliferation
 stops ovulation
 |  | 
        |  | 
        
        | Term 
 
        | where are progesterone receptors |  | Definition 
 
        | genital, mammary, CNS (hypothalamus) |  | 
        |  | 
        
        | Term 
 
        | what is the role of progesterone in pregnancy |  | Definition 
 
        | maintains it supresses mensturation and uterine contraction
 proliferation of mammary acini
 |  | 
        |  | 
        
        | Term 
 
        | why not use a progesterone contraceptive all alone |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | what are the uses of progesterone contraceptives |  | Definition 
 
        | ovarian supression: dysmenorrhea, endometrosis, histurism, uterine bleeding 
 hormone replacement: combined with estrogen
 
 fibroadenomas
 fibrocysts
 PID
 
 cycle regulation
 |  | 
        |  | 
        
        | Term 
 
        | in general why is progesterone added to estrogen contraceptives, why aernt progesterone side effects a big deal |  | Definition 
 
        | avoid side effects of estrogen 
 progesterone side effects usually go away after 1 year
 |  | 
        |  | 
        
        | Term 
 
        | what are the side effects of progesterone contraceptives (11) |  | Definition 
 
        | spotting amenorrhea
 decreased HDL
 increased LDL
 edema
 weight gain: fat deposition
 bloating
 acne
 histuism
 
 impaired glucose tolerance: longer term, short term increases basal insulin
 
 MI and thrombosis in women >35 who smoke
 |  | 
        |  | 
        
        | Term 
 
        | MOA of the morning after pill |  | Definition 
 
        | combination oral contraceptive in a high dose |  | 
        |  | 
        
        | Term 
 
        | administration of the morning after pill |  | Definition 
 
        | taken within 72 hours of intercourse ineffective after 7 days (cannot un-implant)
 |  | 
        |  | 
        
        | Term 
 
        | what is the 21 patch made of |  | Definition 
 
        | ethinyl estradiol norelgestromin |  | 
        |  | 
        
        | Term 
 
        | administration of 21 patch |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  |